prescription helvetica,sans-serif; font-size: 1em; background-color: #92d2dd; border: medium solid #333333; text-align: center;">Complete breakage of the DNA molecule is called double-strand break.

The ATM protein is responsible for their detection and "decides" whether to repair them or not, ie of the survival of the cell.

This explains his involvement in the heart of the cancer process.

 

Breaks

Thumbnail imageThe DNA molecule has a shape well known with its two strands linked together in a double helix. But it can undergo various alterations and among these, full of breaks called double-strand breaks (DSB).
Thumbnail image"Non-desirable" DSB may be due to various factors like:
  • Exposure to radiation (radioactivity, X rays, ultraviolet ...)
  • Exposure to chemical agents (chemotherapy, toxins, pollution ...), to certain viruses, deprivation of oxygen or nutrients.
DSBs are also associated with normal "physiological" situations in the life of the cell:
  • The normal function of developing specific immune defenses.
  • Cell division: whether during meiosis, the process of creation of reproductive cells (sperm and ova), or during mitosis (cell division into two identical daughter cells).
The role of the ATM protein is directly linked to the DSB. It is present in every cell (in the nucleus and cytoplasm), ready to intervene if these lesions occur. Under normal circumstances, the ATM proteins are grouped in pairs: dimers. In this state, they cancel each other out, leaving the cell cycle proceed normally.

ATM: DNA controller

Many proteins are involved in these control mechanisms of potential anomalies throughout the cell cycle. The ATM protein is one of them. It is responsible for detecting DNA double-strand breaks. It does this by itself or through other proteins such as 53BP1 seen on the video below being recruited at the breaks where the DNA of cells is damaged by a laser.

Film description: cells genetically engineered to express a fluorescent protein 53BP1 were exposed to laser radiation of a few micrometers in diameter that generates DNA damage in their nuclei (areas where the fluorescence disappears in both nuclei at the beginning of the film). Immediately, the 53BP1 protein which was dispersed in the nucleus of cells come to focus at the level of detected lesions and thus contribute to the development of cellular responses.


Thumbnail image While at rest, the ATM protein were grouped in pairs to inactivate each other, the signal of the DSB separates them and they activate by the addition of a phosphorus atom (procass named "phosphorylation"). Becoming active, proteins ATM trigger cell cycle arrest in S phase (DNA duplication) or G2 (control of genetic material, see Cell cycle).

Then, depending on the "diagnosis" may be engaged:

Thumbnail image- A process of DNA repair involving, among others, the protein complex MRN (MRE11, RAD50, NBS1) and the BRCA1 protein. For information, the lack of functional MRE11 causes the ATL syndrome (AtaxieTélangiectasie-Like) and the absence of BRCA1 leads to a very high risk of breast and ovarian cancer (65% and 45%, compared to 12% and 1.4% in the general population)


Thumbnail imageThumbnail image- A destructive process involving the protein P53, another essential protein since it is found in 50% of cancers in an altered form.

This occurs in most body cells and makes ATM indispensable everywhere. This explains the wide range of symptoms presented by AT patients.

We can also understand that the development of treatments is difficult, as the chemistry of drugs can treat only a portion of these symptoms. The gene therapy, that is to say correcting the ATM gene, seems therefore to be the only way to cure the disease, but it will be difficult and without guarantee of repairing the harm already done.

However, the central role of ATM in the body implies that the research is interested in it.

HERE IS OUR REAL HOPE!!!

L' AT, c'est quoi?

L'ataxie télangiectasie (AT) est une maladie rare, neurodégénérative et immunodépressive, maladie héréditaire qui affecte de nombreuses parties du corps et provoque de graves incapacités... SUITE

La recherche

La recherche sur le gène ATM en France et dans le monde. Comment combattre une maladie comme l'ataxie télangiectasie? Les projets scientifiques d'AT Europe.

Carte des soignants

La carte de tous les soignants proches de l'AT en France (DOM-TOM compris), avec les centres de compétences de nos réseaux partenaires CEREDIH et NEUROGENE et les soignants, médecins et paramédicaux, indiqués par les familles.

Agenda

 
Sur la course Vertigo en 2013 et 2014!
1km parcouru sur un tapis=1€! (pendant 2 jours en 2015)
1€ par contrat de vente en 2015 (>1000)!
Sur l'Etape du Tour 2014!
Sur la course Vertigo en 2013 et 2014!
Pour les Foulées du Tertre depuis 2012!

Organisez votre évènement!

Sports

Fêtes et spectacles

Stands et ventes

Règles et conseils

Réseau ATEurope

         
 
Forgot Login?   Sign up  

Etudes ouvertes aux familles

CEREDIH

La base de données française tenue par le CEREDIH, partenaire privilégié d'ATEurope, renferme probablement les données médicales les plus complètes au monde et toutes les mutations génétiques des personnes françaises atteintes d'AT. Parlez-en à vos médecins!

La base de données française

CURIE

Dans le cadre de la recherche d'un lien entre cancer du sein et gène ATM, l'étude CoF-AT de l'institut Curie rassemble des données sur les femmes hétérozygotes pour ce gène, c'est-à-dire porteuses saines d'une copie déficiente du gène comme peuvent l'être les mamans des enfants atteints d'AT et d'autres membres de leur famille. Faites-vous connaître!

Étude CoF-AT
de
l'institut Curie

Global AT family data project

ATCP aux USA vient de mettre en place une base de données mondiale liée à l'AT. Complémentaire de celle du CEREDIH, elle permet aux familles concernées de transmettre des données qui n'étaient pas recueillies jusque là, comme les imageries de type IRM ou scanner ou des informations liées aux aptitudes, au comportement ou encore à l'alimentation, etc. Parallèlement, un programme de recueil de 500 génomes complets est mis en place. Vous pouvez participer!

La base mondiale des autres données

Copyright © 2024 ATEurope. All Rights Reserved.
Joomla! is Free Software released under the GNU General Public License.